PIK3CD and pancreatic neoplasm: Moreover, treatment of pancreatic cancer cells by valproic acid, a histone deacetylase inhibitor, has been shown to promote NK cell-mediated lysis of tumors by activation of PI3K/Akt signaling pathway (Figure 2; Shi P. et al., 2014).